2025 Session (83rd) A AB284 R2 984
Amendment No. 984
Senate Amendment to Assembly Bill No. 284 Second Reprint (BDR S-571)
Proposed by: Senate Committee on Finance
Amends: Summary: No Title: Yes Preamble: No Joint Sponsorship: No Digest: Yes
ASSEMBLY ACTION Initial and Date | SENATE ACTION Initial and Date
Adopted Lost | Adopted Lost
Concurred In Not | Concurred In Not
Receded Not | Receded Not
EXPLANATION: Matter in (1) blue bold italics is new language in the original
bill; (2) variations of green bold underlining is language proposed to be added in
this amendment; (3) red strikethrough is deleted language in the original bill; (4)
purple double strikethrough is language proposed to be deleted in this amendment;
(5) orange double underlining is deleted language in the original bill proposed to be
retained in this amendment.
-
DAN/EWR Date: 6/1/2025
A.B. No. 284—Requires the Director of the Department of Health and Human
Services to seek to establish certain rates of reimbursement
under Medicaid for certain devices to treat epilepsy.
(BDR S-571)
*A_AB284_R2_984*
Page 1 of 4

Senate Amendment No. 984 to Assembly Bill No. 284 Second Reprint Page 3
ASSEMBLY BILL NO. 284–ASSEMBLYMEMBER BROWN-MAY
FEBRUARY 25, 2025
_______________
Referred to Committee on Health and Human Services
SUMMARY—Requires the Director of the Department of Health and Human
Services to seek to establish certain rates of reimbursement
under Medicaid for certain devices to treat epilepsy.
(BDR S-571)
FISCAL NOTE: Effect on Local Government: No.
Effect on the State: Yes.
~
EXPLANATION – Matter in bolded italics is new; matter between brackets [omitted material] is material to be omitted.
AN ACT relating to Medicaid; requiring the Director of the Department of Health
and Human Services to seek to establish certain rates of reimbursement
under Medicaid for vagus nerve stimulation therapy devices [,] and
replacement parts for such a device ; [and the procedures necessary to
implant, repair or replace a part of such a device;] making an
appropriation; and providing other matters properly relating thereto.
Legislative Counsel’s Digest:
1 Existing law requires the Department of Health and Human Services to administer the
2 Medicaid program. (NRS 422.270) Section 2 of this bill requires the Director of the
3 Department to submit to the United States Secretary of Health and Human Services a request
4 to include under Medicaid to provide rates of reimbursement greater than or equal to 82
5 percent of the cost for: (1) a vagus nerve stimulation therapy device prescribed for the
6 treatment of epilepsy; and (2) any replacement part for such a device . [; and (3) the procedure
7 necessary to implant, repair or replace a part of such a device.] Section 2 also clarifies that the
8 rates of reimbursement established for the cost of a vagus nerve stimulation therapy device
9 and any replacement part for such a device must be separate from and in addition to the rates
10 of reimbursement for medical care necessary for the implantation or repair of such a device or
11 the replacement of a part for the device. Section 1 of this bill makes an appropriation to and
12 authorizes expenditures by the Division of Health Care Financing and Policy of the
13 Department for certain costs associated with making the increases to rates of reimbursement
14 under Medicaid required by section 2.
THE PEOPLE OF THE STATE OF NEVADA, REPRESENTED IN
SENATE AND ASSEMBLY, DO ENACT AS FOLLOWS:
1 Section 1. 1. There is hereby appropriated from the State General Fund to
2 the Division of Health Care Financing and Policy of the Department of Health and
3 Human Services for carrying out the provisions of section 2 of this act and making

Senate Amendment No. 984 to Assembly Bill No. 284 Second Reprint Page 4
1 upgrades to computer systems necessary to carry out those provisions the following
2 sums:
3 For the Fiscal Year 2025-2026 .......................................................... $54,728
4 For the Fiscal Year 2026-2027 ........................................................ $240,004
5 2. Any balance of the sums appropriated by subsection 1 remaining at the end
6 of the respective fiscal years must not be committed for expenditure after June 30
7 of the respective fiscal years by the entity to which the appropriation is made or any
8 entity to which money from the appropriation is granted or otherwise transferred in
9 any manner, and any portion of the appropriated money remaining must not be
10 spent for any purpose after September 18, 2026, and September 17, 2027,
11 respectively, by either the entity to which the money was appropriated or the entity
12 to which the money was subsequently granted or transferred, and must be reverted
13 to the State General Fund on or before September 18, 2026, and September 17,
14 2027, respectively.
15 3. Expenditure of the following sums not appropriated from the State General
16 Fund or the State Highway Fund is hereby authorized by the Division of Health
17 Care Financing and Policy of the Department of Health and Human Services for the
18 same purposes as set forth in subsection 1:
19 For the Fiscal Year 2025-2026 ........................................................ $188,270
20 For the Fiscal Year 2026-2027 ........................................................ $700,098
21 Sec. 2. 1. On or before October 1, 2025, the Director of the Department of
22 Health and Human Services shall submit to the United States Secretary of Health
23 and Human Services a request to include under Medicaid:
24 (a) A rate of reimbursement for a vagus nerve stimulation therapy device
25 prescribed for the treatment of epilepsy that is greater than or equal to 82 percent of
26 the acquisition cost of such a device; and
27 (b) A rate of reimbursement for any replacement part for a vagus nerve
28 stimulation therapy device prescribed for the treatment of epilepsy that is greater
29 than or equal to 82 percent of the acquisition cost of such a replacement part . [; and
30 (c) A rate of reimbursement for the procedure necessary to implant, repair or
31 replace a part of a vagus nerve stimulation therapy device prescribed for the
32 treatment of epilepsy that is greater than or equal to 82 percent of the cost of the
33 procedure.]
34 2. The rates of reimbursement established pursuant to [paragraphs (a) and (b)
35 of] subsection 1 must be separate from and in addition to the rates of
36 reimbursement for the medical care necessary for implantation or repair of a vagus
37 nerve stimulation therapy device or the replacement of a part for such a device.
38 3. The request submitted pursuant to subsection 1 must be supported using
39 methods for determining rates of reimbursement accepted by the Secretary.
40 Sec. 3. 1. This section and section 1 of this act become effective on July 1,
41 2025.
42 2. Section 2 of this act becomes effective on March 1, 2026.

[DELETED:   A  D  ( T P J DN SI  IA L   | A L  C N   | C N  R N   | R N  ]
[DELETED:  PBN.AB-M I O S RNA2  t D o t D o H a H t s t e c r o r M f c d t t e EE r o r a p o s a d m aE p ( 4 S 2 o t b r t D o t o c f ( a v n s t d f t e b t D o H C F a P o t   S 1  1  T t H]
[DELETED:  P u s F F  2  A o o e a s f a p a S 1 2 a S 1 2 r t t 2  3  E F C s F F  S 2  1  O H a  ( A r o r f a v n s t d p t  ( A r o r f a r p f a v n s t  ( A r a p o a v n s t d p f t t p  2  T o s 1 m b s f a i a t t r o r n  3  T m  S 3  1  T 2  2  S]